Evidence map›Paper›PMID 33940309›Full record

ArticleThrombosis research2021

Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis.

Matthew Moll, Rebecca L Zon, Katelyn W Sylvester, Jessica Rimsans, Evan C Chen, Auyon J Ghosh, Eric Abston, Andy Kim, Henry Rutherford, Xhoi Mitre and 10 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Thrombosis research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Matthew MollChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Rebecca L ZonMedical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Katelyn W SylvesterDepartment of Pharmacy Services, Brigham and Women's Hospital, Boston, MA, USA.
Jessica RimsansDepartment of Pharmacy Services, Brigham and Women's Hospital, Boston, MA, USA.
Evan C ChenHematology, Dana-Farber Cancer Institute, Boston, MA, USA.
Auyon J GhoshChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Eric AbstonDivision of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA.
Andy KimDepartment of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
Henry RutherfordDepartment of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
Xhoi MitreDepartment of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
Aaron HakimDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Nathan T ConnellDivision of Hematology, Brigham and Women's Hospital, Boston, MA, USA.
Elisabeth BattinelliDivision of Hematology, Brigham and Women's Hospital, Boston, MA, USA.
Laura E FredenburghDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Rebecca M BaronDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Brian D HobbsChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Michael H ChoChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Murray A MittlemanDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Ann E WoolleyDepartment of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
Jean M ConnorsHematology, Dana-Farber Cancer Institute, Boston, MA, USA; Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: jconnors@bwh.harvard.edu.

Funding

Multi-omic Subtyping of Chronic Obstructive Pulmonary DiseaseK08HL136928 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI HOBBS, BRIAN DANIEL · 2017 to 2021
$864k
NHLBI NIH HHS K08 HL136928
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HeparinAnticoagulantsHumansIntensive Care UnitsPropensity ScoreRetrospective StudiesSARS-CoV-2AnticoagulantsHeparinAnticoagulationCOVID-19Critical careHeparinIntermediate dose

Identifiers

PMID33940309
PMCPMC8053596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.